George Nuki

7.9k total citations · 1 hit paper
51 papers, 3.5k citations indexed

About

George Nuki is a scholar working on Rheumatology, Nephrology and Surgery. According to data from OpenAlex, George Nuki has authored 51 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Rheumatology, 20 papers in Nephrology and 17 papers in Surgery. Recurrent topics in George Nuki's work include Gout, Hyperuricemia, Uric Acid (20 papers), Case Reports on Hematomas (15 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). George Nuki is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (20 papers), Case Reports on Hematomas (15 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). George Nuki collaborates with scholars based in United Kingdom, United States and Spain. George Nuki's co-authors include Michael Doherty, Peter A. Simkin, Barry Bresnihan, Dorothy McCabe, Kelsey M. Jordan, Weiya Zhang, Thomas Bardin, Bryan Williams, Karel Pavelká and Rolf Rau and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

George Nuki

50 papers receiving 3.3k citations

Hit Papers

Treatment of rheumatoid arthritis with recombinant human ... 1998 2026 2007 2016 1998 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George Nuki United Kingdom 24 1.6k 1.5k 1.1k 721 441 51 3.5k
Peter T. Chapman New Zealand 35 1.2k 0.8× 971 0.6× 766 0.7× 515 0.7× 480 1.1× 82 3.2k
Keith E. Holley United States 38 795 0.5× 1.4k 0.9× 609 0.5× 744 1.0× 386 0.9× 85 4.3k
A Meyrier France 34 579 0.4× 2.1k 1.4× 440 0.4× 890 1.2× 488 1.1× 155 3.9k
Jung‐Yoon Choe South Korea 36 1.9k 1.2× 537 0.4× 669 0.6× 1.0k 1.4× 1.0k 2.4× 218 4.4k
Cèsar Díaz‐Torné Spain 30 1.0k 0.6× 543 0.4× 596 0.5× 390 0.5× 326 0.7× 153 2.7k
N. Lawrence Edwards United States 27 874 0.5× 1.4k 0.9× 933 0.8× 656 0.9× 158 0.4× 80 2.5k
Volker Vielhauer Germany 36 878 0.5× 1.6k 1.0× 331 0.3× 913 1.3× 1.9k 4.2× 67 4.4k
Bin Yoo South Korea 33 1.7k 1.0× 374 0.2× 386 0.3× 666 0.9× 674 1.5× 213 3.9k
G. K. van der Hem Netherlands 23 628 0.4× 862 0.6× 285 0.3× 458 0.6× 548 1.2× 70 3.5k
Debashish Danda India 29 1.1k 0.7× 548 0.4× 501 0.5× 418 0.6× 627 1.4× 180 3.1k

Countries citing papers authored by George Nuki

Since Specialization
Citations

This map shows the geographic impact of George Nuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Nuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Nuki more than expected).

Fields of papers citing papers by George Nuki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Nuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Nuki. The network helps show where George Nuki may publish in the future.

Co-authorship network of co-authors of George Nuki

This figure shows the co-authorship network connecting the top 25 collaborators of George Nuki. A scholar is included among the top collaborators of George Nuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Nuki. George Nuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saag, Kenneth G., Nicola Dalbeth, Chang‐Fu Kuo, et al.. (2025). Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies. Contemporary Clinical Trials. 151. 107843–107843.
2.
Meeson, Richard, Rory J. Todhunter, Gordon Blunn, George Nuki, & Andrew A. Pitsillides. (2019). Spontaneous dog osteoarthritis — a One Medicine vision. Nature Reviews Rheumatology. 15(5). 273–287. 76 indexed citations
3.
Hui, Michelle, Alison Carr, Stewart Cameron, et al.. (2017). The British Society for Rheumatology Guideline for the Management of Gout. Lara D. Veeken. 56(7). e1–e20. 209 indexed citations
4.
Hui, C. M., Alison Carr, Stewart Cameron, et al.. (2017). The British Society for Rheumatology Guideline for the Management of Gout. Lara D. Veeken. 56(7). 1247–1247. 4 indexed citations
5.
Nuki, George. (2014). An appraisal of the 2012 American College of Rheumatology Guidelines for the Management of Gout. Current Opinion in Rheumatology. 26(2). 152–161. 20 indexed citations
7.
Richette, Pascal, Fernando Pérez-Ruiz, Michael Doherty, et al.. (2014). Improving cardiovascular and renal outcomes in gout: what should we target?. Nature Reviews Rheumatology. 10(11). 654–661. 151 indexed citations
8.
Doherty, Michael, Tim Jansen, George Nuki, et al.. (2012). Gout: why is this curable disease so seldom cured?. Annals of the Rheumatic Diseases. 71(11). 1765–1770. 189 indexed citations
9.
Khanna, Puja, George Nuki, Thomas Bardin, et al.. (2012). Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey. Health and Quality of Life Outcomes. 10(1). 117–117. 149 indexed citations
10.
Nuki, George. (2008). Colchicine: Its mechanism of action and efficacy in crystal-induced inflammation. Current Rheumatology Reports. 10(3). 218–227. 145 indexed citations
11.
Jordan, Kelsey M., J. S. Cameron, M L Snaith, et al.. (2007). British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout. Lara D. Veeken. 46(8). 1372–1374. 406 indexed citations
12.
Nuki, George & Peter A. Simkin. (2006). A concise history of gout and hyperuricemia and their treatment.. Arthritis Research & Therapy. 8(Suppl 1). S1–S1. 213 indexed citations
13.
Nuki, George. (2006). Treatment of Crystal Arthropathy—History and Advances. Rheumatic Disease Clinics of North America. 32(2). 333–357. 11 indexed citations
15.
Millward‐Sadler, S.J., M. O. Wright, Keigo Nishida, et al.. (1999). Integrin-regulated secretion of interleukin 4. The Journal of Cell Biology. 145(1). 5 indexed citations
16.
Jobanputra, Paresh, et al.. (1996). Modulation of human chondrocyte integrins by inflammatory synovial fluid. Arthritis & Rheumatism. 39(8). 1430–1432. 16 indexed citations
17.
Jobanputra, Paresh & George Nuki. (1994). Nonsteroidal anti-inflammatory drugs in the treatment of osteoarthritis. Current Opinion in Rheumatology. 6(4). 433–439. 13 indexed citations
20.
Nuki, George. (1980). The aetiopathogenesis of osteoarthrosis. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026